These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 8183954

  • 1. Characterization of human immunodeficiency virus type 1 Pr55gag membrane association in a cell-free system: requirement for a C-terminal domain.
    Platt EJ, Haffar OK.
    Proc Natl Acad Sci U S A; 1994 May 10; 91(10):4594-8. PubMed ID: 8183954
    [Abstract] [Full Text] [Related]

  • 2. The nonmyristylated Pr160gag-pol polyprotein of human immunodeficiency virus type 1 interacts with Pr55gag and is incorporated into viruslike particles.
    Park J, Morrow CD.
    J Virol; 1992 Nov 10; 66(11):6304-13. PubMed ID: 1383561
    [Abstract] [Full Text] [Related]

  • 3. Increased incorporation of chimeric human immunodeficiency virus type 1 gp120 proteins into Pr55gag virus-like particles by an Epstein-Barr virus gp220/350-derived transmembrane domain.
    Deml L, Kratochwil G, Osterrieder N, Knüchel R, Wolf H, Wagner R.
    Virology; 1997 Aug 18; 235(1):10-25. PubMed ID: 9300033
    [Abstract] [Full Text] [Related]

  • 4. Interaction and co-encapsidation of human immunodeficiency virus type 1 Gag and Vif recombinant proteins.
    Huvent I, Hong SS, Fournier C, Gay B, Tournier J, Carrière C, Courcoul M, Vigne R, Spire B, Boulanger P.
    J Gen Virol; 1998 May 18; 79 ( Pt 5)():1069-81. PubMed ID: 9603321
    [Abstract] [Full Text] [Related]

  • 5. Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly.
    Spearman P, Wang JJ, Vander Heyden N, Ratner L.
    J Virol; 1994 May 18; 68(5):3232-42. PubMed ID: 8151785
    [Abstract] [Full Text] [Related]

  • 6. The I domain is required for efficient plasma membrane binding of human immunodeficiency virus type 1 Pr55Gag.
    Sandefur S, Varthakavi V, Spearman P.
    J Virol; 1998 Apr 18; 72(4):2723-32. PubMed ID: 9525590
    [Abstract] [Full Text] [Related]

  • 7. Membrane binding of human immunodeficiency virus type 1 matrix protein in vivo supports a conformational myristyl switch mechanism.
    Spearman P, Horton R, Ratner L, Kuli-Zade I.
    J Virol; 1997 Sep 18; 71(9):6582-92. PubMed ID: 9261380
    [Abstract] [Full Text] [Related]

  • 8. Identification of a region in the Pr55gag-polyprotein essential for HIV-1 particle formation.
    von Poblotzki A, Wagner R, Niedrig M, Wanner G, Wolf H, Modrow S.
    Virology; 1993 Apr 18; 193(2):981-5. PubMed ID: 8460500
    [Abstract] [Full Text] [Related]

  • 9. Human immunodeficiency virus type 1 MA deletion mutants expressed in baculovirus-infected cells: cis and trans effects on the Gag precursor assembly pathway.
    Chazal N, Gay B, Carrière C, Tournier J, Boulanger P.
    J Virol; 1995 Jan 18; 69(1):365-75. PubMed ID: 7983731
    [Abstract] [Full Text] [Related]

  • 10. Requirement of the Pr55gag precursor for incorporation of the Vpr product into human immunodeficiency virus type 1 viral particles.
    Lavallée C, Yao XJ, Ladha A, Göttlinger H, Haseltine WA, Cohen EA.
    J Virol; 1994 Mar 18; 68(3):1926-34. PubMed ID: 8107252
    [Abstract] [Full Text] [Related]

  • 11. Phenotypic characterization of insertion mutants of the human immunodeficiency virus type 1 Gag precursor expressed in recombinant baculovirus-infected cells.
    Chazal N, Carrière C, Gay B, Boulanger P.
    J Virol; 1994 Jan 18; 68(1):111-22. PubMed ID: 8254720
    [Abstract] [Full Text] [Related]

  • 12. Differential membrane binding of the human immunodeficiency virus type 1 matrix protein.
    Zhou W, Resh MD.
    J Virol; 1996 Dec 18; 70(12):8540-8. PubMed ID: 8970978
    [Abstract] [Full Text] [Related]

  • 13. Mutations in the protease gene of human immunodeficiency virus type 1 affect release and stability of virus particles.
    Park J, Morrow CD.
    Virology; 1993 Jun 18; 194(2):843-50. PubMed ID: 8503189
    [Abstract] [Full Text] [Related]

  • 14. A novel fluorescence resonance energy transfer assay demonstrates that the human immunodeficiency virus type 1 Pr55Gag I domain mediates Gag-Gag interactions.
    Derdowski A, Ding L, Spearman P.
    J Virol; 2004 Feb 18; 78(3):1230-42. PubMed ID: 14722278
    [Abstract] [Full Text] [Related]

  • 15. Relationship between human immunodeficiency virus type 1 Gag multimerization and membrane binding.
    Ono A, Demirov D, Freed EO.
    J Virol; 2000 Jun 18; 74(11):5142-50. PubMed ID: 10799589
    [Abstract] [Full Text] [Related]

  • 16. Assembly and extracellular release of chimeric HIV-1 Pr55gag retrovirus-like particles.
    Wagner R, Deml L, Fliessbach H, Wanner G, Wolf H.
    Virology; 1994 Apr 18; 200(1):162-75. PubMed ID: 7510434
    [Abstract] [Full Text] [Related]

  • 17. Incorporation of Vpr into human immunodeficiency virus type 1: role of conserved regions within the P6 domain of Pr55gag.
    Checroune F, Yao XJ, Göttlinger HG, Bergeron D, Cohen EA.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep 01; 10(1):1-7. PubMed ID: 7648278
    [Abstract] [Full Text] [Related]

  • 18. A simple procedure to generate chimeric Pr55gag virus-like particles expressing the principal neutralization domain of human immunodeficiency virus type 1.
    Brand D, Mallet F, Truong C, Roingeard P, Goudeau A, Barin F.
    J Virol Methods; 1995 Feb 01; 51(2-3):153-68. PubMed ID: 7537750
    [Abstract] [Full Text] [Related]

  • 19. Independent segregation of human immunodeficiency virus type 1 Gag protein complexes and lipid rafts.
    Ding L, Derdowski A, Wang JJ, Spearman P.
    J Virol; 2003 Feb 01; 77(3):1916-26. PubMed ID: 12525626
    [Abstract] [Full Text] [Related]

  • 20. Mapping of functionally important residues of a cysteine-histidine box in the human immunodeficiency virus type 1 nucleocapsid protein.
    Dorfman T, Luban J, Goff SP, Haseltine WA, Göttlinger HG.
    J Virol; 1993 Oct 01; 67(10):6159-69. PubMed ID: 8371356
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.